NCT01524770View on ClinicalTrials.gov

A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Diabetes Mellitus, Type 2
Interventions
BIOLOGICAL

Dulaglutide

Administered by subcutaneous (SC) injection

Trial Locations (1)

32117

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01524770 - A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe | Biotech Hunter | Biotech Hunter